Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - vaginalcreme - clindamycinum 20 mg ut clindamycini phosphas, sorbitani stearas, polysorbatum 60, propylenglycolum 50 mg, acidum stearicum, alcohol cetylicus et stearylicus 32.1 mg, cetylis palmitas, paraffinum liquidum, alcohol benzylicus 10 mg, aqua purificata, ad unguentum pro 1 g. - batterica vaginosen - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - soluzione topica - clindamycinum 10 mg a clindamycini phosphas, propylenglycolum, excipiens ad una soluzione per 1 ml. - l'acne vulgaris - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

pfizer ag - clindamycinum - emulsion zur anwendung auf der haut - clindamycinum 10 mg ut clindamycini phosphas, glycerolum (85 per centum), natrii laurates sarcosinas, acidum stearicum, glyceroli stearas, alcohol cetylicus et stearylicus 25 mg, alcohol isostearylicus, e 218 3 mg, aqua purificata, ad emulsionem pro 1 g. - akne vulgaris - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

viatris pharma gmbh - clindamycinum, tretinoinum - gel - clindamycini phosphas 12.0 mg corresp. clindamycinum 10.0 mg, tretinoinum 0.25 mg, acidum citricum, dinatrii edetas, polysorbatum 80, trometamolum, carbomerum 981, glycerolum, e 321 0.2 mg, propylis parahydroxybenzoas 0.3 mg, e 218 1.5 mg, aqua purificata q.s. ad gelatum pro 1 g. - trattamento topico dell'acne vulgaris - synthetika